Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Analysts Set Integra LifeSciences Holdings Corporation (NASDAQ:IART) Price Target at $14.40

Summary by defenseworld.net
Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) has earned a consensus recommendation of “Reduce” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokers that have covered the stoc…

1 Articles

defenseworld.netdefenseworld.net
Center

Analysts Set Integra LifeSciences Holdings Corporation (NASDAQ:IART) Price Target at $14.40

Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) has earned a consensus recommendation of “Reduce” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokers that have covered the stoc…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Monday, March 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

New Jersey icon

New Jersey

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal